Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance
Author:
Funder
Canadian Institutes for Health Research (CIHR)
Publisher
Elsevier BV
Subject
Cancer Research,Infectious Diseases,Virology
Reference98 articles.
1. Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness;Abram;Antimicrob. Agents Chemother.,2013
2. Dolutegravir versus placebo in subjects harbouring HIV-1 with integrase inhibitor resistance associated substitutions: 48-week results from VIKING-4, a randomized study;Akil;Antivir. Ther.,2015
3. HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia;Armenia;J. Antimicrob. Chemother.,2015
4. Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor;Bar-Magen;J. Virol.,2010
5. Dual therapy treatment strategies for the management of patients infected with HIV: a systematic review of current evidence in ARV-naive or ARV-experienced, virologically suppressed patients;Baril;PLoS One,2016
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Medicinal chemistry perspectives on the development of piperazine-containing HIV-1 inhibitors;Bioorganic & Medicinal Chemistry;2024-02
2. Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model;Frontiers in Pharmacology;2023-12-12
3. Preliminary report of transmitted drug resistance to integrase strand chain transfer inhibitors in treatment-naïve HIV infected patients;Diagnostic Microbiology and Infectious Disease;2023-12
4. Dolutegravir resistance in sub-Saharan Africa: should resource-limited settings be concerned for future treatment?;Frontiers in Virology;2023-09-25
5. Retrospective longitudinal analysis of low-level viremia among HIV-1 infected adults on antiretroviral therapy in Kenya;eClinicalMedicine;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3